Handlungsempfehlung nach der Leitlinie ,,Purpura Schönlein-Henoch“

ISSN： 0026-9298

Source： Monatsschrift Kinderheilkunde, Vol.161, Iss.8, 2013-08, pp. : 738-739

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Purpura Schönlein-Henoch

By Huppertz H.-I.

Monatsschrift Kinderheilkunde, Vol. 154, Iss. 9, 2006-09 ,pp. : 865-871

Springer Publishing Company

Access to resources Recommend Favorite

Handlungsempfehlung nach der Leitlinie ,,Neuroblastom“

By Simon T.

Monatsschrift Kinderheilkunde, Vol. 162, Iss. 3, 2014-03 ,pp. : 257-258

Springer Publishing Company

Access to resources Recommend Favorite

Handlungsempfehlung nach der Leitlinie ,,Sichelzellkrankheit“: Schmerzkrisen bei Patienten mit Sichelzellerkrankung

By Dickerhoff R. Sinha K.

Monatsschrift Kinderheilkunde, Vol. 162, Iss. 1, 2014-01 ,pp. : 68-69

Springer Publishing Company

Access to resources Recommend Favorite

Henoch-Schönlein purpura nephritis: an update

By Davin Jean-Claude Weening Jan

European Journal of Pediatrics, Vol. 160, Iss. 12, 2001-12 ,pp. : 689-695

Springer Publishing Company

Access to resources Recommend Favorite

THE ELEVATED MARKERS OF HYPERCOAGULABILITY IN CHILDREN WITH HENOCH–SCHÖNLEIN PURPURA

By Yilmaz Deniz Kavakli Kaan Ozkayin Nese

Pediatric Hematology and Oncology, Vol. 22, Iss. 1, 2005-01 ,pp. : 41-48

Informa Healthcare

Access to resources Recommend Favorite